Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Injuries | 16 | 2015 | 764 | 3.020 |
Why?
|
Brain Injuries, Traumatic | 6 | 2022 | 374 | 1.780 |
Why?
|
Decompressive Craniectomy | 4 | 2021 | 13 | 1.720 |
Why?
|
Recovery of Function | 5 | 2017 | 441 | 1.470 |
Why?
|
Ganglia, Spinal | 6 | 2016 | 71 | 1.450 |
Why?
|
Brain Neoplasms | 8 | 2023 | 1243 | 1.430 |
Why?
|
Glioblastoma | 5 | 2020 | 334 | 1.290 |
Why?
|
Stress, Psychological | 4 | 2022 | 557 | 1.220 |
Why?
|
Neurodegenerative Diseases | 3 | 2023 | 250 | 1.170 |
Why?
|
Blood-Brain Barrier | 6 | 2022 | 145 | 1.130 |
Why?
|
Mental Disorders | 4 | 2020 | 823 | 1.110 |
Why?
|
Neuronal Plasticity | 3 | 2018 | 273 | 1.070 |
Why?
|
Spinal Cord Injuries | 4 | 2019 | 310 | 1.050 |
Why?
|
Sciatic Neuropathy | 2 | 2016 | 6 | 0.990 |
Why?
|
Hippocampus | 7 | 2022 | 830 | 0.980 |
Why?
|
Brain | 9 | 2022 | 3002 | 0.940 |
Why?
|
Wakefulness | 2 | 2023 | 98 | 0.920 |
Why?
|
Spinal Cord | 4 | 2021 | 302 | 0.890 |
Why?
|
Nerve Regeneration | 5 | 2014 | 81 | 0.880 |
Why?
|
Neurons | 7 | 2016 | 1966 | 0.870 |
Why?
|
Ketorolac | 1 | 2023 | 17 | 0.840 |
Why?
|
Ultrasonics | 1 | 2023 | 37 | 0.840 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2022 | 10 | 0.830 |
Why?
|
Cerebrospinal Fluid Leak | 1 | 2022 | 44 | 0.810 |
Why?
|
Disease Models, Animal | 16 | 2022 | 4355 | 0.800 |
Why?
|
Astrocytes | 2 | 2023 | 249 | 0.780 |
Why?
|
Neurosurgery | 2 | 2020 | 79 | 0.760 |
Why?
|
Neuronavigation | 1 | 2021 | 7 | 0.740 |
Why?
|
Cranial Sinuses | 1 | 2021 | 12 | 0.740 |
Why?
|
Hydrocephalus | 1 | 2023 | 245 | 0.690 |
Why?
|
Occupational Health | 1 | 2020 | 44 | 0.680 |
Why?
|
Humans | 77 | 2023 | 124299 | 0.680 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 261 | 0.670 |
Why?
|
Tissue Engineering | 4 | 2009 | 174 | 0.670 |
Why?
|
Neurosurgical Procedures | 4 | 2020 | 307 | 0.660 |
Why?
|
DNA Repair Enzymes | 1 | 2019 | 40 | 0.640 |
Why?
|
DNA Modification Methylases | 1 | 2019 | 43 | 0.640 |
Why?
|
Ultrasonography, Interventional | 1 | 2021 | 193 | 0.640 |
Why?
|
Occupational Exposure | 1 | 2020 | 129 | 0.640 |
Why?
|
Cervical Cord | 1 | 2019 | 9 | 0.630 |
Why?
|
Alzheimer Disease | 2 | 2023 | 786 | 0.630 |
Why?
|
Neck Injuries | 1 | 2019 | 24 | 0.620 |
Why?
|
Hemangioblastoma | 1 | 2018 | 12 | 0.620 |
Why?
|
Sepsis | 1 | 2023 | 479 | 0.610 |
Why?
|
Animals | 35 | 2023 | 34145 | 0.600 |
Why?
|
Cerebrospinal Fluid Pressure | 1 | 2017 | 16 | 0.580 |
Why?
|
Ectopic Gene Expression | 1 | 2017 | 3 | 0.560 |
Why?
|
Intervertebral Disc Degeneration | 1 | 2017 | 13 | 0.560 |
Why?
|
Intervertebral Disc | 1 | 2017 | 12 | 0.560 |
Why?
|
Rats | 12 | 2022 | 3686 | 0.550 |
Why?
|
Solute Carrier Family 12, Member 2 | 1 | 2016 | 7 | 0.540 |
Why?
|
Schwann Cells | 2 | 2014 | 59 | 0.540 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2016 | 125 | 0.540 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2016 | 11 | 0.540 |
Why?
|
Emotions | 2 | 2016 | 364 | 0.530 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2017 | 356 | 0.520 |
Why?
|
Myelin Proteins | 2 | 2014 | 76 | 0.520 |
Why?
|
Male | 41 | 2021 | 60962 | 0.520 |
Why?
|
Neural Stem Cells | 2 | 2014 | 124 | 0.500 |
Why?
|
Norepinephrine | 1 | 2016 | 173 | 0.500 |
Why?
|
Vascular Neoplasms | 1 | 2016 | 32 | 0.500 |
Why?
|
Cerebellar Neoplasms | 1 | 2018 | 285 | 0.490 |
Why?
|
Central Nervous System Diseases | 1 | 2016 | 105 | 0.480 |
Why?
|
Failed Back Surgery Syndrome | 1 | 2014 | 3 | 0.480 |
Why?
|
Cerebellum | 1 | 2018 | 416 | 0.480 |
Why?
|
Action Potentials | 2 | 2016 | 500 | 0.480 |
Why?
|
Middle Aged | 24 | 2021 | 26451 | 0.470 |
Why?
|
Coronavirus Infections | 1 | 2020 | 358 | 0.470 |
Why?
|
Young Adult | 13 | 2021 | 8976 | 0.470 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 374 | 0.470 |
Why?
|
Lumbar Vertebrae | 3 | 2023 | 112 | 0.470 |
Why?
|
Peripheral Nervous System Neoplasms | 2 | 2004 | 12 | 0.460 |
Why?
|
Neuralgia | 1 | 2014 | 45 | 0.460 |
Why?
|
Meningioma | 1 | 2016 | 120 | 0.460 |
Why?
|
Brain Injury, Chronic | 1 | 2014 | 21 | 0.460 |
Why?
|
Up-Regulation | 2 | 2016 | 862 | 0.450 |
Why?
|
Neuroglia | 1 | 2016 | 201 | 0.450 |
Why?
|
S100 Proteins | 1 | 2014 | 45 | 0.450 |
Why?
|
Receptors, Cell Surface | 2 | 2014 | 469 | 0.450 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 139 | 0.450 |
Why?
|
Neurilemmoma | 2 | 2004 | 48 | 0.450 |
Why?
|
Meningeal Neoplasms | 1 | 2016 | 185 | 0.450 |
Why?
|
Craniotomy | 3 | 2023 | 108 | 0.440 |
Why?
|
Adult | 23 | 2023 | 29386 | 0.440 |
Why?
|
Neurologic Examination | 2 | 2014 | 195 | 0.440 |
Why?
|
Athletic Injuries | 1 | 2014 | 58 | 0.430 |
Why?
|
Toll-Like Receptor 4 | 1 | 2014 | 144 | 0.430 |
Why?
|
Mice, Inbred C57BL | 10 | 2022 | 4425 | 0.410 |
Why?
|
Warfare | 1 | 2012 | 35 | 0.410 |
Why?
|
Pandemics | 1 | 2020 | 1102 | 0.400 |
Why?
|
Rats, Sprague-Dawley | 6 | 2018 | 1228 | 0.400 |
Why?
|
Blast Injuries | 1 | 2012 | 58 | 0.400 |
Why?
|
Aged | 16 | 2020 | 19478 | 0.390 |
Why?
|
Cell Transplantation | 1 | 2012 | 45 | 0.390 |
Why?
|
Sleep Wake Disorders | 1 | 2014 | 169 | 0.390 |
Why?
|
Memory Disorders | 1 | 2014 | 236 | 0.380 |
Why?
|
Peripheral Nerve Injuries | 1 | 2012 | 37 | 0.380 |
Why?
|
Cervical Vertebrae | 3 | 2017 | 113 | 0.380 |
Why?
|
Imipramine | 1 | 2011 | 18 | 0.370 |
Why?
|
Aging | 2 | 2017 | 1184 | 0.350 |
Why?
|
Cell Proliferation | 4 | 2021 | 2304 | 0.350 |
Why?
|
Cognition Disorders | 2 | 2012 | 553 | 0.350 |
Why?
|
GPI-Linked Proteins | 3 | 2023 | 98 | 0.340 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 645 | 0.330 |
Why?
|
Female | 30 | 2021 | 66235 | 0.330 |
Why?
|
Motor Activity | 1 | 2013 | 522 | 0.330 |
Why?
|
Mice | 15 | 2023 | 17727 | 0.330 |
Why?
|
Neoplastic Stem Cells | 3 | 2021 | 300 | 0.330 |
Why?
|
Nerve Sheath Neoplasms | 3 | 2009 | 23 | 0.320 |
Why?
|
Axons | 4 | 2021 | 393 | 0.320 |
Why?
|
Neurogenesis | 1 | 2011 | 190 | 0.320 |
Why?
|
Peripheral Nerves | 1 | 2009 | 85 | 0.320 |
Why?
|
Adolescent | 12 | 2023 | 19298 | 0.320 |
Why?
|
Critical Care | 2 | 2014 | 651 | 0.310 |
Why?
|
Mass Screening | 1 | 2014 | 783 | 0.310 |
Why?
|
Brachial Plexus | 2 | 2009 | 20 | 0.300 |
Why?
|
Cognition | 1 | 2013 | 730 | 0.290 |
Why?
|
Retrospective Studies | 11 | 2023 | 16226 | 0.290 |
Why?
|
Tissue and Organ Harvesting | 1 | 2008 | 40 | 0.290 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 1254 | 0.290 |
Why?
|
Anxiety | 1 | 2014 | 966 | 0.290 |
Why?
|
Calcium Signaling | 2 | 2023 | 242 | 0.280 |
Why?
|
Tissue Scaffolds | 1 | 2008 | 73 | 0.280 |
Why?
|
Depression | 2 | 2022 | 1243 | 0.270 |
Why?
|
Immunohistochemistry | 3 | 2017 | 1684 | 0.270 |
Why?
|
Decompression, Surgical | 2 | 2004 | 93 | 0.270 |
Why?
|
Analgesics, Opioid | 2 | 2023 | 409 | 0.270 |
Why?
|
Amyotrophic Lateral Sclerosis | 2 | 2021 | 146 | 0.270 |
Why?
|
Time Factors | 8 | 2022 | 6268 | 0.270 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 2535 | 0.260 |
Why?
|
Eye Movements | 2 | 2017 | 69 | 0.250 |
Why?
|
Cerebral Cortex | 2 | 2021 | 455 | 0.250 |
Why?
|
RNA, Messenger | 4 | 2017 | 2824 | 0.250 |
Why?
|
Aged, 80 and over | 5 | 2017 | 6470 | 0.250 |
Why?
|
Mice, Transgenic | 5 | 2021 | 2408 | 0.240 |
Why?
|
Ulnar Nerve Compression Syndromes | 1 | 2004 | 2 | 0.240 |
Why?
|
Elbow | 1 | 2004 | 7 | 0.240 |
Why?
|
Ulnar Nerve | 1 | 2004 | 13 | 0.240 |
Why?
|
Germinoma | 1 | 2004 | 31 | 0.240 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2004 | 12 | 0.230 |
Why?
|
Nervous System Neoplasms | 1 | 2004 | 11 | 0.230 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2004 | 19 | 0.220 |
Why?
|
Spinal Cord Neoplasms | 1 | 2004 | 71 | 0.220 |
Why?
|
Brain Concussion | 3 | 2016 | 229 | 0.220 |
Why?
|
Postoperative Complications | 4 | 2023 | 3067 | 0.220 |
Why?
|
Glasgow Coma Scale | 2 | 2014 | 204 | 0.220 |
Why?
|
G-Quadruplexes | 1 | 2023 | 9 | 0.220 |
Why?
|
Morphine Derivatives | 1 | 2023 | 6 | 0.220 |
Why?
|
Decompression | 1 | 2023 | 5 | 0.220 |
Why?
|
Chondrocytes | 2 | 2017 | 48 | 0.220 |
Why?
|
Infrared Rays | 1 | 2023 | 24 | 0.210 |
Why?
|
Aptamers, Nucleotide | 1 | 2023 | 28 | 0.210 |
Why?
|
Clonidine | 1 | 2023 | 35 | 0.210 |
Why?
|
Pyrans | 2 | 2021 | 7 | 0.210 |
Why?
|
Diffusion Tensor Imaging | 2 | 2016 | 238 | 0.210 |
Why?
|
Arousal | 1 | 2023 | 81 | 0.210 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2023 | 49 | 0.210 |
Why?
|
Hedgehog Proteins | 2 | 2016 | 189 | 0.200 |
Why?
|
Intracranial Pressure | 5 | 2017 | 182 | 0.200 |
Why?
|
Animals, Newborn | 2 | 2016 | 1008 | 0.200 |
Why?
|
Magnetic Resonance Imaging | 7 | 2023 | 3578 | 0.200 |
Why?
|
Prognosis | 4 | 2019 | 4549 | 0.200 |
Why?
|
Anesthetics, Local | 1 | 2023 | 80 | 0.200 |
Why?
|
Epinephrine | 1 | 2023 | 177 | 0.200 |
Why?
|
Intracranial Aneurysm | 2 | 2018 | 93 | 0.190 |
Why?
|
Brain Edema | 3 | 2018 | 69 | 0.190 |
Why?
|
Endarterectomy, Carotid | 1 | 2022 | 97 | 0.190 |
Why?
|
Doxycycline | 1 | 2022 | 117 | 0.190 |
Why?
|
Transplantation, Homologous | 2 | 2014 | 661 | 0.180 |
Why?
|
Hyponatremia | 1 | 2022 | 72 | 0.180 |
Why?
|
Treatment Outcome | 10 | 2022 | 12288 | 0.180 |
Why?
|
Autophagy-Related Protein 5 | 1 | 2021 | 11 | 0.180 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 1658 | 0.180 |
Why?
|
Phosphoproteins | 2 | 2023 | 404 | 0.180 |
Why?
|
Carotid Stenosis | 1 | 2022 | 138 | 0.180 |
Why?
|
Coccyx | 1 | 2020 | 3 | 0.180 |
Why?
|
Surgical Wound Infection | 1 | 2023 | 265 | 0.180 |
Why?
|
Pain, Postoperative | 1 | 2023 | 257 | 0.170 |
Why?
|
SMARCB1 Protein | 1 | 2020 | 37 | 0.170 |
Why?
|
Sleep | 1 | 2023 | 340 | 0.170 |
Why?
|
DNA-Binding Proteins | 2 | 2021 | 2055 | 0.170 |
Why?
|
Seizures | 2 | 2016 | 878 | 0.170 |
Why?
|
Patient Readmission | 1 | 2023 | 376 | 0.160 |
Why?
|
Cell Survival | 3 | 2019 | 805 | 0.160 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2019 | 32 | 0.160 |
Why?
|
Cognitive Dysfunction | 1 | 2023 | 231 | 0.160 |
Why?
|
Cancer Pain | 2 | 2017 | 24 | 0.160 |
Why?
|
Child, Preschool | 5 | 2017 | 14040 | 0.160 |
Why?
|
Collagen Type II | 2 | 2017 | 24 | 0.160 |
Why?
|
Risk Factors | 5 | 2023 | 10138 | 0.160 |
Why?
|
Eye Movement Measurements | 2 | 2017 | 3 | 0.160 |
Why?
|
Ischemic Postconditioning | 1 | 2018 | 4 | 0.160 |
Why?
|
Phosphopyruvate Hydratase | 2 | 2016 | 31 | 0.160 |
Why?
|
Infant | 3 | 2020 | 12471 | 0.150 |
Why?
|
Hydrogen Peroxide | 1 | 2019 | 113 | 0.150 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2016 | 136 | 0.150 |
Why?
|
Ocimum sanctum | 1 | 2018 | 2 | 0.150 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 353 | 0.150 |
Why?
|
Cell Count | 2 | 2016 | 252 | 0.150 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 549 | 0.150 |
Why?
|
Blotting, Western | 2 | 2018 | 1108 | 0.150 |
Why?
|
Length of Stay | 2 | 2014 | 1307 | 0.150 |
Why?
|
Chronic Pain | 1 | 2020 | 129 | 0.150 |
Why?
|
Genes, Neoplasm | 1 | 2018 | 80 | 0.150 |
Why?
|
Biomarkers | 3 | 2016 | 2971 | 0.150 |
Why?
|
Glucosides | 1 | 2018 | 46 | 0.140 |
Why?
|
Neoplasms | 2 | 2023 | 2759 | 0.140 |
Why?
|
Flavonoids | 1 | 2018 | 78 | 0.140 |
Why?
|
Connective Tissue Growth Factor | 1 | 2017 | 19 | 0.140 |
Why?
|
Quality Improvement | 1 | 2023 | 635 | 0.140 |
Why?
|
Thoracic Vertebrae | 1 | 2017 | 69 | 0.140 |
Why?
|
Bumetanide | 1 | 2016 | 7 | 0.140 |
Why?
|
Nogo Receptor 1 | 2 | 2014 | 9 | 0.140 |
Why?
|
User-Computer Interface | 2 | 2008 | 155 | 0.140 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 401 | 0.130 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 59 | 0.130 |
Why?
|
Cell Membrane Permeability | 1 | 2016 | 73 | 0.130 |
Why?
|
Trauma Centers | 1 | 2018 | 178 | 0.130 |
Why?
|
Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2017 | 69 | 0.130 |
Why?
|
Calpain | 1 | 2016 | 41 | 0.130 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2016 | 31 | 0.130 |
Why?
|
Behavior, Animal | 2 | 2022 | 492 | 0.130 |
Why?
|
Cerebrovascular Circulation | 2 | 2017 | 433 | 0.130 |
Why?
|
Head Protective Devices | 1 | 2016 | 24 | 0.130 |
Why?
|
Pancreatic Stellate Cells | 1 | 2016 | 7 | 0.130 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 467 | 0.130 |
Why?
|
Visual Perception | 1 | 2017 | 124 | 0.130 |
Why?
|
Catheters, Indwelling | 1 | 2017 | 155 | 0.130 |
Why?
|
Ammonia | 1 | 2016 | 74 | 0.130 |
Why?
|
Substance P | 1 | 2016 | 34 | 0.130 |
Why?
|
Melatonin | 1 | 2016 | 25 | 0.130 |
Why?
|
Thrombocytopenia | 1 | 2018 | 226 | 0.130 |
Why?
|
TRPV Cation Channels | 1 | 2016 | 34 | 0.130 |
Why?
|
Facial Nerve | 1 | 2016 | 24 | 0.130 |
Why?
|
Radiosurgery | 1 | 2017 | 106 | 0.130 |
Why?
|
Nerve Growth Factors | 1 | 2016 | 72 | 0.130 |
Why?
|
Tubulin | 1 | 2016 | 104 | 0.130 |
Why?
|
Survival Rate | 2 | 2018 | 2019 | 0.130 |
Why?
|
Evoked Potentials | 1 | 2016 | 145 | 0.130 |
Why?
|
MicroRNAs | 1 | 2023 | 840 | 0.130 |
Why?
|
Neuroma, Acoustic | 1 | 2016 | 28 | 0.130 |
Why?
|
Intracranial Hypertension | 1 | 2017 | 121 | 0.130 |
Why?
|
Protease Inhibitors | 1 | 2016 | 94 | 0.130 |
Why?
|
Preoperative Care | 2 | 2016 | 349 | 0.120 |
Why?
|
Microglia | 1 | 2016 | 95 | 0.120 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2016 | 87 | 0.120 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2016 | 174 | 0.120 |
Why?
|
Electrophysiology | 1 | 2016 | 270 | 0.120 |
Why?
|
Ischemia | 1 | 2018 | 354 | 0.120 |
Why?
|
Blood Platelets | 1 | 2018 | 325 | 0.120 |
Why?
|
Endothelial Cells | 1 | 2019 | 525 | 0.120 |
Why?
|
Exosomes | 1 | 2015 | 43 | 0.120 |
Why?
|
Frontotemporal Dementia | 1 | 2015 | 43 | 0.120 |
Why?
|
Sex Factors | 2 | 2016 | 1267 | 0.120 |
Why?
|
Abducens Nerve Diseases | 1 | 2014 | 7 | 0.120 |
Why?
|
Pyrroles | 1 | 2016 | 179 | 0.120 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 1891 | 0.120 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2014 | 18 | 0.120 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 577 | 0.120 |
Why?
|
Ocular Motility Disorders | 1 | 2015 | 38 | 0.120 |
Why?
|
Myocardial Infarction | 1 | 2022 | 1011 | 0.120 |
Why?
|
S100 Calcium Binding Protein A6 | 1 | 2014 | 2 | 0.120 |
Why?
|
Child | 6 | 2017 | 24434 | 0.110 |
Why?
|
Glycoproteins | 1 | 2016 | 369 | 0.110 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 669 | 0.110 |
Why?
|
Single-Blind Method | 1 | 2014 | 237 | 0.110 |
Why?
|
Stroke | 1 | 2022 | 974 | 0.110 |
Why?
|
SOXB1 Transcription Factors | 1 | 2014 | 58 | 0.110 |
Why?
|
Horses | 1 | 2014 | 89 | 0.110 |
Why?
|
Critical Care Nursing | 1 | 2014 | 6 | 0.110 |
Why?
|
S100 Calcium Binding Protein beta Subunit | 1 | 2014 | 16 | 0.110 |
Why?
|
Photolysis | 1 | 2013 | 9 | 0.110 |
Why?
|
Medulla Oblongata | 1 | 2013 | 22 | 0.110 |
Why?
|
Analysis of Variance | 1 | 2016 | 1017 | 0.110 |
Why?
|
Hyperbaric Oxygenation | 1 | 2013 | 20 | 0.110 |
Why?
|
Trauma Severity Indices | 1 | 2014 | 88 | 0.110 |
Why?
|
Pyrazoles | 1 | 2016 | 307 | 0.110 |
Why?
|
Physical Exertion | 1 | 2014 | 81 | 0.110 |
Why?
|
Neuroblastoma | 1 | 2019 | 519 | 0.110 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 515 | 0.110 |
Why?
|
Infant, Newborn | 2 | 2017 | 8180 | 0.110 |
Why?
|
Brain Stem Neoplasms | 1 | 2013 | 39 | 0.110 |
Why?
|
Injury Severity Score | 1 | 2014 | 225 | 0.110 |
Why?
|
Athletes | 1 | 2014 | 64 | 0.110 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 1584 | 0.110 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 1341 | 0.110 |
Why?
|
Explosions | 1 | 2012 | 8 | 0.100 |
Why?
|
Rats, Wistar | 1 | 2014 | 360 | 0.100 |
Why?
|
Magnetic Resonance Angiography | 1 | 2013 | 169 | 0.100 |
Why?
|
Follow-Up Studies | 3 | 2017 | 5103 | 0.100 |
Why?
|
Glutamic Acid | 1 | 2013 | 201 | 0.100 |
Why?
|
Hematoma, Subdural, Chronic | 1 | 2012 | 10 | 0.100 |
Why?
|
Hypothermia, Induced | 1 | 2013 | 166 | 0.100 |
Why?
|
Immunogenetic Phenomena | 1 | 2012 | 1 | 0.100 |
Why?
|
Receptors, Glucocorticoid | 1 | 2012 | 122 | 0.100 |
Why?
|
Sciatic Nerve | 1 | 2012 | 56 | 0.100 |
Why?
|
Neuroimaging | 1 | 2015 | 340 | 0.100 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 2122 | 0.100 |
Why?
|
Age Factors | 2 | 2016 | 2801 | 0.100 |
Why?
|
Brachial Plexus Neuritis | 1 | 2011 | 5 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2014 | 581 | 0.090 |
Why?
|
Mice, Knockout | 3 | 2014 | 3752 | 0.090 |
Why?
|
Progesterone | 1 | 2013 | 625 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 1899 | 0.090 |
Why?
|
Cell Line, Tumor | 4 | 2021 | 3341 | 0.090 |
Why?
|
Cells, Cultured | 4 | 2019 | 3052 | 0.090 |
Why?
|
Anticonvulsants | 1 | 2013 | 380 | 0.090 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2013 | 510 | 0.090 |
Why?
|
Hypoxia | 1 | 2012 | 246 | 0.090 |
Why?
|
Cerebral Ventricles | 1 | 2011 | 82 | 0.090 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2011 | 142 | 0.090 |
Why?
|
Neuropsychological Tests | 1 | 2014 | 925 | 0.090 |
Why?
|
Intracranial Hemorrhages | 1 | 2011 | 73 | 0.090 |
Why?
|
Feasibility Studies | 2 | 2016 | 763 | 0.090 |
Why?
|
Intensive Care Units | 1 | 2014 | 483 | 0.090 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 685 | 0.080 |
Why?
|
Chronic Disease | 1 | 2014 | 1185 | 0.080 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2009 | 10 | 0.080 |
Why?
|
Education, Medical, Graduate | 1 | 2014 | 515 | 0.080 |
Why?
|
Pyridines | 1 | 2011 | 228 | 0.080 |
Why?
|
Severity of Illness Index | 2 | 2015 | 2887 | 0.080 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2009 | 64 | 0.080 |
Why?
|
Guided Tissue Regeneration | 1 | 2008 | 3 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 1 | 2011 | 316 | 0.080 |
Why?
|
Cartilage, Articular | 1 | 2009 | 57 | 0.080 |
Why?
|
Databases, Factual | 1 | 2013 | 1174 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 365 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2021 | 2505 | 0.080 |
Why?
|
Lung Diseases | 1 | 2012 | 383 | 0.080 |
Why?
|
Hemangioma | 1 | 2009 | 94 | 0.080 |
Why?
|
Myelin Sheath | 1 | 2009 | 132 | 0.080 |
Why?
|
Incidence | 1 | 2016 | 3079 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2018 | 1318 | 0.070 |
Why?
|
Wound Healing | 1 | 2012 | 458 | 0.070 |
Why?
|
Factor VIIa | 1 | 2008 | 24 | 0.070 |
Why?
|
beta Catenin | 1 | 2009 | 206 | 0.070 |
Why?
|
Osteoarthritis | 1 | 2009 | 86 | 0.070 |
Why?
|
Stress, Mechanical | 1 | 2008 | 171 | 0.070 |
Why?
|
Hemostatics | 1 | 2008 | 58 | 0.070 |
Why?
|
Texas | 1 | 2016 | 3580 | 0.070 |
Why?
|
Dementia | 1 | 2012 | 450 | 0.070 |
Why?
|
Positive-Pressure Respiration | 1 | 2007 | 82 | 0.070 |
Why?
|
Smoking | 1 | 2012 | 1037 | 0.070 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 288 | 0.070 |
Why?
|
Neuroprotective Agents | 1 | 2008 | 157 | 0.060 |
Why?
|
Electromyography | 2 | 2021 | 164 | 0.060 |
Why?
|
Interleukin-1beta | 2 | 2016 | 162 | 0.060 |
Why?
|
Autophagy | 2 | 2021 | 395 | 0.060 |
Why?
|
Microsurgery | 1 | 2005 | 69 | 0.060 |
Why?
|
Neurofibroma | 1 | 2004 | 6 | 0.060 |
Why?
|
Internship and Residency | 1 | 2014 | 1177 | 0.060 |
Why?
|
Mutation | 3 | 2023 | 5805 | 0.060 |
Why?
|
Recombinant Proteins | 1 | 2008 | 1391 | 0.060 |
Why?
|
Respiration, Artificial | 1 | 2007 | 461 | 0.060 |
Why?
|
Intracranial Hypotension | 1 | 2003 | 10 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2007 | 375 | 0.050 |
Why?
|
Spinal Puncture | 1 | 2003 | 53 | 0.050 |
Why?
|
Skull Base | 1 | 2003 | 54 | 0.050 |
Why?
|
3' Untranslated Regions | 1 | 2023 | 165 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 1685 | 0.050 |
Why?
|
Carotid Arteries | 1 | 2022 | 150 | 0.050 |
Why?
|
Functional Laterality | 2 | 2013 | 182 | 0.040 |
Why?
|
Apoptosis | 2 | 2018 | 1787 | 0.040 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2020 | 24 | 0.040 |
Why?
|
Gene Regulatory Networks | 1 | 2023 | 355 | 0.040 |
Why?
|
Patient Selection | 1 | 2004 | 688 | 0.040 |
Why?
|
Low Back Pain | 1 | 2020 | 37 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 2088 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 157 | 0.040 |
Why?
|
Tight Junctions | 1 | 2019 | 39 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 93 | 0.040 |
Why?
|
Malondialdehyde | 1 | 2018 | 35 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 2019 | 108 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 1 | 2018 | 124 | 0.040 |
Why?
|
Peroxidase | 1 | 2018 | 62 | 0.040 |
Why?
|
Permeability | 1 | 2019 | 120 | 0.040 |
Why?
|
Metabolomics | 1 | 2022 | 419 | 0.040 |
Why?
|
Phytochemicals | 1 | 2018 | 8 | 0.040 |
Why?
|
Thrombopoiesis | 1 | 2018 | 11 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2018 | 152 | 0.040 |
Why?
|
Superoxide Dismutase | 1 | 2018 | 139 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2018 | 103 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 548 | 0.040 |
Why?
|
Algorithms | 2 | 2014 | 1612 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 240 | 0.040 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 1064 | 0.030 |
Why?
|
Narcotics | 1 | 2017 | 63 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2017 | 62 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 316 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 816 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 340 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2018 | 859 | 0.030 |
Why?
|
Pedigree | 1 | 2020 | 1596 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2018 | 261 | 0.030 |
Why?
|
Capsaicin | 1 | 2016 | 18 | 0.030 |
Why?
|
Spine | 1 | 2017 | 143 | 0.030 |
Why?
|
Nerve Growth Factor | 1 | 2016 | 24 | 0.030 |
Why?
|
Binding Sites | 1 | 2019 | 1296 | 0.030 |
Why?
|
Swine | 2 | 2011 | 1173 | 0.030 |
Why?
|
Nanotubes | 1 | 2015 | 13 | 0.030 |
Why?
|
Stents | 1 | 2022 | 885 | 0.030 |
Why?
|
Prions | 1 | 2015 | 13 | 0.030 |
Why?
|
United States | 3 | 2018 | 10765 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 233 | 0.030 |
Why?
|
Patch-Clamp Techniques | 1 | 2016 | 280 | 0.030 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2016 | 115 | 0.030 |
Why?
|
Motion Pictures | 1 | 2014 | 8 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 354 | 0.030 |
Why?
|
Pancreas | 1 | 2016 | 217 | 0.030 |
Why?
|
Automation | 1 | 2014 | 63 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2015 | 76 | 0.030 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2014 | 27 | 0.030 |
Why?
|
Mice, Nude | 1 | 2016 | 710 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 670 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 328 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2018 | 477 | 0.030 |
Why?
|
Certification | 1 | 2014 | 67 | 0.030 |
Why?
|
Immunoblotting | 1 | 2014 | 313 | 0.030 |
Why?
|
SNARE Proteins | 1 | 2013 | 22 | 0.030 |
Why?
|
Schools, Medical | 1 | 2014 | 111 | 0.030 |
Why?
|
Anisotropy | 1 | 2013 | 122 | 0.030 |
Why?
|
Photic Stimulation | 1 | 2014 | 220 | 0.030 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2013 | 83 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2013 | 154 | 0.030 |
Why?
|
Sports | 1 | 2014 | 61 | 0.030 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2013 | 131 | 0.030 |
Why?
|
Neural Inhibition | 1 | 2013 | 108 | 0.030 |
Why?
|
Risk Assessment | 1 | 2022 | 3380 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2014 | 318 | 0.030 |
Why?
|
Radiography | 1 | 2015 | 827 | 0.030 |
Why?
|
ROC Curve | 1 | 2013 | 561 | 0.020 |
Why?
|
Atrophy | 1 | 2012 | 236 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 701 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 2614 | 0.020 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 292 | 0.020 |
Why?
|
Phenotype | 1 | 2021 | 4256 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2011 | 60 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2011 | 107 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2018 | 1930 | 0.020 |
Why?
|
Neuropeptides | 1 | 2011 | 114 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2014 | 1320 | 0.020 |
Why?
|
Oximetry | 1 | 2011 | 162 | 0.020 |
Why?
|
Students, Medical | 1 | 2014 | 356 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2011 | 197 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2009 | 51 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2011 | 246 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 3137 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2009 | 58 | 0.020 |
Why?
|
Memory | 1 | 2012 | 362 | 0.020 |
Why?
|
Learning | 1 | 2012 | 363 | 0.020 |
Why?
|
Gene Expression | 1 | 2014 | 1569 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 274 | 0.020 |
Why?
|
Logistic Models | 1 | 2012 | 1802 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2009 | 225 | 0.020 |
Why?
|
Homeostasis | 1 | 2011 | 692 | 0.020 |
Why?
|
Respiration | 1 | 2007 | 121 | 0.020 |
Why?
|
Electroencephalography | 1 | 2011 | 868 | 0.020 |
Why?
|
Biopsy | 1 | 2009 | 1236 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2012 | 3268 | 0.020 |
Why?
|
Prospective Studies | 1 | 2014 | 6075 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 4535 | 0.010 |
Why?
|
Blood Patch, Epidural | 1 | 2003 | 6 | 0.010 |
Why?
|